FDA clears GE Healthcare's x-ray AI for endotracheal tube placement

2017 03 09 14 05 24 948 Chest Lung Xray 400

The U.S. Food and Drug Administration (FDA) has cleared GE Healthcare's artificial intelligence (AI) software for assessing endotracheal tube placement on x-ray images.

GE's Critical Care Suite 2.0 software features algorithms that help radiologists triage cases and reduce review time, according to the firm. It is loaded on a mobile x-ray system and detects endotracheal tubes on chest x-rays, providing an assessment of tube positioning. Its results are then sent immediately to the radiologist.

GE has been distributing Critical Care Suite 2.0 under the FDA's COVID-19 imaging guidance since November 2020. This new clearance will allow it to be used outside of a public health emergency, GE said.

Page 1 of 367
Next Page